Monica Morrow American surgeon
Morrow, Monica.
Morrow, M.
VIAF ID: 315223590 (Personal)
Permalink: http://viaf.org/viaf/315223590
Preferred Forms
- 100 0 _ ‡a Monica Morrow ‡c American surgeon
- 100 1 _ ‡a Morrow, M.
-
- 100 1 _ ‡a Morrow, Monica
- 100 1 _ ‡a Morrow, Monica (sparse)
-
- 100 1 _ ‡a Morrow, Monica
-
-
-
- 100 1 _ ‡a Morrow, Monica
-
4xx's: Alternate Name Forms (6)
Works
Title | Sources |
---|---|
Breast disease, 1999: | |
Locoregional Recurrence After Sentinel Lymph Node Dissection With or Without Axillary Dissection in Patients With Sentinel Lymph Node Metastases: Long-term Follow-up From the American College of Surgeons Oncology Group (Alliance) ACOSOG Z0011 Random | |
Locoregional treatment of primary breast cancer: consensus recommendations from an International Expert Panel | |
Management of the clinically node-negative axilla: what have we learned from the clinical trials? | |
Management of the Node-Positive Axilla in Breast Cancer in 2017: Selecting the Right Option. | |
Margines chirurgiczny podczas lumpektomii z powodu raka piersi : więcej nie oznacza lepiej | |
Margins in breast cancer: How much is enough? | |
Margins in breast conservation: a clinician's perspective and what the literature tells us. | |
Margins in DCIS: Does Residual Disease Provide an Answer? | |
Matched T cell repertoire analysis of peripheral blood and tumor-infiltrating lymphocytes (TILs) in early stage breast cancer (ESBC) patients (pts) treated with pre-operative cryoablation (cryo) and/or Ipilimumab (Ipi). | |
Measuring quality of life in oncologic breast surgery: a systematic review of patient-reported outcome measures | |
Menopause is a determinant of breast adipose inflammation | |
Meta-analysis of pre-operative magnetic resonance imaging (MRI) and surgical treatment for breast cancer | |
Metabolic Obesity, Adipose Inflammation and Elevated Breast Aromatase in Women with Normal Body Mass Index. | |
Modified radical mastectomy with knife technique | |
Most Breast Cancer Patients with T1-2 Tumors and One to Three Positive Lymph Nodes Do Not Need Postmastectomy Radiotherapy. | |
MRI and breast cancer: role in detection, diagnosis, and staging. | |
Multifocal/Multicentric Ipsilateral Invasive Breast Carcinomas with Similar Histology: Is Multigene Testing of All Individual Foci Necessary? | |
The need for lymph node dissection in nonmetastatic breast cancer | |
Nipple-sparing mastectomy for breast cancer and risk-reducing surgery: the Memorial Sloan-Kettering Cancer Center experience. | |
Number of lymph nodes removed in sentinel lymph node-negative breast cancer patients is significantly related to patient age and tumor size: a new source of bias in morbidity assessment? | |
Oncologic Outcomes After Treatment for MRI Occult Breast Cancer (pT0N+). | |
Optimal surgical management for high-risk populations | |
Outcomes for Women with Minimal-Volume Ductal Carcinoma In Situ Completely Excised at Core Biopsy | |
Patient Experiences and Clinician Views on the Role of Radiation Therapy for Ductal Carcinoma In Situ. | |
Patient-reported Quality of Life and Satisfaction With Cosmetic Outcomes After Breast Conservation and Mastectomy With and Without Reconstruction: Results of a Survey of Breast Cancer Survivors | |
Patients with a history of epithelial ovarian cancer presenting with a breast and/or axillary mass | |
Perioperative breast MRI is not associated with lower locoregional recurrence rates in DCIS patients treated with or without radiation | |
A prospective feasibility trial to determine the significance of the sentinel node gradient in breast cancer: a predictor of nodal metastasis location | |
A prospective study of variability in mammographic density during the menstrual cycle | |
Regulatory T Cells Exhibit Distinct Features in Human Breast Cancer | |
Reply to "Implications of abnormal preoperative axillary imaging in the post Z011 era". | |
Reply to L.B. Marks et al. | |
Reply to S.M. Sorscher and A.B. Hafeez Bhatti. | |
Results of the Lynn Sage Second-Opinion Program for local therapy in patients with breast carcinoma. Changes in management and determinants of where care is delivered. | |
Rethinking the Local Therapy of Breast Cancer: Integration of Biology and Anatomy | |
Sentinel node biopsy after neoadjuvant chemotherapy: a new standard for patients with axillary metastases? | |
Sentinel node skills verification and surgeon performance: data from a multicenter clinical trial for early-stage breast cancer | |
Should breast density influence patient selection for breast-conserving surgery? | |
Skin Flap Necrosis After Mastectomy With Reconstruction: A Prospective Study | |
Society of Surgical Oncology Breast Disease Working Group Statement on Prophylactic (Risk-Reducing) Mastectomy | |
Staging system for breast cancer: revisions for the 6th edition of the AJCC Cancer Staging Manual | |
Standard for the management of ductal carcinoma in situ of the breast (DCIS). | |
Standard Pathologic Features Can Be Used to Identify a Subset of Estrogen Receptor-Positive, HER2 Negative Patients Likely to Benefit from Neoadjuvant Chemotherapy | |
Surgeon Attitudes and Use of MRI in Patients Newly Diagnosed with Breast Cancer | |
Surgeon Influence on Variation in Receipt of Contralateral Prophylactic Mastectomy For Women With Breast Cancer | |
Surgeon perspectives about local therapy for breast carcinoma. | |
Surgery of the primary tumor in metastatic breast cancer: closing the barn door after the horse has bolted? | |
Surgical aspects of inflammatory breast cancer | |
Surgical management of the axilla: do intramammary nodes matter? | |
Symptom experience and quality of life of women following breast cancer treatment. | |
Systemic Correlates of White Adipose Tissue Inflammation in Early-Stage Breast Cancer | |
Tamoxifen, Raloxifene, and the Prevention of Breast Cancer1 | |
Tamoxifen use in patients with ductal carcinoma in situ and T1a/b N0 invasive carcinoma | |
Treatment-associated toxicities reported by patients with early-stage invasive breast cancer | |
Treatment Decision Making and Genetic Testing for Breast Cancer: Mainstreaming Mutations | |
Trends and controversies in multidisciplinary care of the patient with breast cancer | |
Trends in Reoperation After Initial Lumpectomy for Breast Cancer: Addressing Overtreatment in Surgical Management | |
Troubleshooting Sentinel Lymph Node Biopsy in Breast Cancer Surgery | |
Tumor Biology Predicts Pathologic Complete Response to Neoadjuvant Chemotherapy in Patients Presenting with Locally Advanced Breast Cancer. | |
Understanding the impact of breast reconstruction on the surgical decision-making process for breast cancer | |
Use of pharmacologic interventions for breast cancer risk reduction: American Society of Clinical Oncology clinical practice guideline | |
What Does a Fellow Need to Know to Build a Successful Academic Clinical Research Career?Advice From Monica Morrow, MD. | |
What is an adequate margin for breast-conserving surgery? Surgeon attitudes and correlates | |
Why Are There So Many Mastectomies in the United States? |